Cargando…

Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Xue, Chen, Jia, Junjun, Gu, Xinyu, Zhou, Lin, Lu, Juan, Zheng, Qiuxian, Su, Yuanshuai, Zheng, Shusen, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515207/ https://www.ncbi.nlm.nih.gov/pubmed/36167691 http://dx.doi.org/10.1038/s41392-022-01159-9

Ejemplares similares

Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
por: Xue, Chen, et al.
Publicado: (2022)

Current understanding of the intratumoral microbiome in various tumors
por: Xue, Chen, et al.
Publicado: (2023)

ALYREF mediates RNA m(5)C modification to promote hepatocellular carcinoma progression
por: Xue, Chen, et al.
Publicado: (2023)

LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility
por: Su, Yuanshuai, et al.
Publicado: (2022)

Functions and underlying mechanisms of miR-650 in human cancers
por: Su, Yuanshuai, et al.
Publicado: (2022)

Effects of 3‐HAA on HCC by Regulating the Heterogeneous Macrophages—A scRNA‐Seq Analysis
por: Xue, Chen, et al.
Publicado: (2023)

The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility
por: Su, Yuanshuai, et al.
Publicado: (2022)

Health and Disease: Akkermansia muciniphila, the Shining Star of the Gut Flora
por: Xue, Chen, et al.
Publicado: (2023)

The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment
por: Xue, Chen, et al.
Publicado: (2022)

Integrated bioinformatics analysis reveals the function and prognostic value of OSBPL3 in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

Role of main RNA modifications in cancer: N(6)-methyladenosine, 5-methylcytosine, and pseudouridine
por: Xue, Chen, et al.
Publicado: (2022)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma
por: Jiang, Jianwen, et al.
Publicado: (2020)

The functional roles of the circRNA/Wnt axis in cancer
por: Xue, Chen, et al.
Publicado: (2022)

Phosphoribosyl Pyrophosphate Amido Transferase: A New Prognostic Biomarker for Hepatocellular Carcinoma
por: Chu, Qingfei, et al.
Publicado: (2022)

Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma
por: Zheng, Qiuxian, et al.
Publicado: (2021)

Uncovering the Association Between m(5)C Regulator-Mediated Methylation Modification Patterns and Tumour Microenvironment Infiltration Characteristics in Hepatocellular Carcinoma
por: Gu, Xinyu, et al.
Publicado: (2021)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
por: Huang, Jian-Hang, et al.
Publicado: (2022)

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review
por: Chu, Qingfei, et al.
Publicado: (2022)

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes
por: Gu, Xinyu, et al.
Publicado: (2021)

Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
por: Wang, Yi, et al.
Publicado: (2023)

Mitochondrial Mechanisms of Apoptosis and Necroptosis in Liver Diseases
por: Chu, Qingfei, et al.
Publicado: (2021)

Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma
por: Chen, Tianxiang, et al.
Publicado: (2012)

Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
por: Kalasekar, Sharanya Maanasi, et al.
Publicado: (2021)

Intratumoral bacteria in uveal melanoma: A case report
por: Vega Escobar, Katherine, et al.
Publicado: (2023)

Awareness of intratumoral bacteria and their potential application in cancer treatment
por: Liang, Yin, et al.
Publicado: (2023)

Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes
por: Shi, Qingmiao, et al.
Publicado: (2023)

A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genes
por: Shi, Qingmiao, et al.
Publicado: (2023)

Intratumor heterogeneity: A new perspective on colorectal cancer research
por: Zheng, Zicheng, et al.
Publicado: (2020)

Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics
por: Goto, Yamato, et al.
Publicado: (2023)

Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma
por: Gao, Benjian, et al.
Publicado: (2021)

Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies
por: Zhang, Qi, et al.
Publicado: (2020)

Multi-Omics Characterizes the Effects and Mechanisms of CD1d in Nonalcoholic Fatty Liver Disease Development
por: Zheng, Qiuxian, et al.
Publicado: (2022)

Spatial intratumor heterogeneity of genetic, epigenetic alterations and temporal clonal evolution in esophageal squamous cell carcinoma
por: Hao, Jia-Jie, et al.
Publicado: (2016)

Multi-omics analysis of the effects of dietary changes and probiotics on diet-induced obesity
por: Jiang, Shiman, et al.
Publicado: (2023)

The modulation relationship of genomic pattern of intratumor heterogeneity and immunity microenvironment heterogeneity in hepatocellular carcinoma
por: Li, Liu-Bo, et al.
Publicado: (2020)

Identification of High-Mobility Group Box 1 (HMGB1) Expression as a Potential Predictor of Rejection and Poor Prognosis After Liver Transplantation
por: Ye, Zhou, et al.
Publicado: (2021)

Altering the intratumoral localization of macrophages to inhibit cancer progression
por: Casazza, Andrea, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m925qovdnl8smdi2ns2jqi0l7e